Bulletin
Investor Alert

June 29, 2021, 9:03 a.m. EDT

Walmart to launch lower-priced insulin offering savings of up to 75%

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Walmart Inc. (WMT)
  • X
    Novo Nordisk A/S ADR (NVO)
  • X
    Dow Jones Industrial Average (DJIA)

or Cancel Already have a watchlist? Log In

By Wallace Witkowski

Walmart Inc. said Tuesday it is launching a lower-priced brand of insulin as a result of working directly with the manufacturer, Novo Nordisk A/S.

Walmart /zigman2/quotes/207374728/composite WMT -0.73% said its private-brand ReliOn NovoLog insulin made by Denmark-based Novo Nordisk /zigman2/quotes/203484366/composite NVO -0.10% would save customers up to 75%. Vials of the insulin are priced at $72.88 apiece, or a savings of up to $101 a vial, while FlexPens are priced at $85.88, or a savings of up to $251 per package, Walmart said.

The prescription insulin will be available exclusively at Walmart pharmacies starting this week, and in Sam’s Club pharmacies in mid-July, the company said. Insulin is used to treat Type 1 and Type 2 diabetes, where the body does not make enough of the hormone which helps blood sugar to enter cells for energy.

In a conference call, Cheryl Pegus, who heads Walmart Health & Wellness, said the insulin was similar to the ReliOn insulin already available at Walmart, but that it was at a lower cost as a result of working directly with Novo Nordisk.

In May, Novo Nordisk raised its guidance for the year after topping earnings expectations for the first quarter.

More than 34 million Americans suffer from some form of diabetes, according to the Centers for Disease Control and Prevention.

Walmart shares are down more than 4% for the year, while U.S. shares of Novo Nordisk are up 19%. Year to date, the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% , which counts Walmart as a component, is up 12%, while the S&P 500 index /zigman2/quotes/210599714/realtime SPX -1.89% is up 14%.

/zigman2/quotes/207374728/composite
US : U.S.: NYSE
$ 140.19
-1.03 -0.73%
Volume: 9.17M
Jan. 21, 2022 4:00p
P/E Ratio
49.09
Dividend Yield
1.57%
Market Cap
$391.73 billion
Rev. per Employee
$248,679
loading...
/zigman2/quotes/203484366/composite
US : U.S.: NYSE
$ 95.36
-0.10 -0.10%
Volume: 1.35M
Jan. 21, 2022 4:00p
P/E Ratio
29.68
Dividend Yield
1.10%
Market Cap
$221.40 billion
Rev. per Employee
$477,136
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
34,265.37
-450.02 -1.30%
Volume: 523.88M
Jan. 21, 2022 4:52p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,397.94
-84.79 -1.89%
Volume: 3.20B
Jan. 21, 2022 4:52p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.